The earnings call highlighted significant challenges, including a sharp revenue decline and ongoing issues with TRICARE payment suspension. However, the company's efforts to reduce costs, improve cash flow, and advance new products like the NiCO pulse oximeter provide some positive outlook for future growth. The appointment of a new CEO also signals a strategic refocus. Despite these efforts, the challenges currently outweigh the positive developments.

Company Guidance

During the Zynex Second Quarter 2025 Earnings Conference Call, the company provided guidance centered around significant operational restructuring and cost reduction initiatives. They reported a net revenue of $22.3 million for the quarter, a decrease from $49.9 million in the same period of 2024, largely due to a temporary payment suspension from TRICARE and sales force reductions. Despite a net loss of $20 million, Zynex achieved a gross profit margin of 68%, with expectations to reduce expenses by approximately $40 million annually through strategic restructuring. The company is refocusing its business model, shifting its sales force towards more profitable segments and enhancing supply chain management to support a return to positive cash flow by the end of the year. Additionally, Zynex is actively working on FDA clearance for its NiCO pulse oximeter, with approval anticipated within six months of an expected August information request from the FDA. The company has also appointed a new CEO, Steven Dyson, to lead its strategic refocus and growth trajectory.

Cost Reduction and Efficiency Improvements

Zynex is implementing a $40 million annualized reduction in expenses through improved supply chain management, a more diversified customer base, and internal restructuring including a 14% reduction in staff primarily at the corporate office.

New Leadership Appointment

Steven Dyson, with over 25 years of experience in the medical technology sector, has been appointed as the new CEO to steer Zynex towards a more optimized payer mix and growth trajectory, starting August 18.

NiCO Pulse Oximeter FDA Submission

The company has submitted its NiCO laser pulse oximeter to the FDA, expecting clearance in approximately 6 months. The device aims to address accuracy issues in current pulse oximeters and could potentially enter a $3.5 billion global market.

Improved Cash Collection

Despite challenges, Zynex collected $26 million in cash during the second quarter, indicating improved efficiency in cash flow management.

Zynex (ZYXI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ZYXI Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 23, 2025	2025 (Q3)	-0.17 / -	0.07	―	―	―
Jul 31, 2025	2025 (Q2)	-0.20 / -0.66	0.04	-1750.00% (-0.70)	―
Apr 29, 2025	2025 (Q1)	-0.24 / -0.33	0	―	―
Mar 11, 2025	2024 (Q4)	0.09 / -0.02	0.04	-150.00% (-0.06)	―
Oct 24, 2024	2024 (Q3)	0.06 / 0.07	0.1	-30.00% (-0.03)	―
Jul 25, 2024	2024 (Q2)	0.08 / 0.04	0.09	-55.56% (-0.05)	―
Apr 30, 2024	2024 (Q1)	0.03 / 0.00	0.04	―	―
Feb 29, 2024	2023 (Q4)	0.17 / 0.04	0.2	-80.00% (-0.16)	―
Oct 26, 2023	2023 (Q3)	0.09 / 0.10	0.13	-23.08% (-0.03)	―
Jul 27, 2023	2023 (Q2)	0.04 / 0.09	0.08	12.50% (<+0.01)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ZYXI Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Jul 31, 2025	$2.23	$1.26	-43.50%
Apr 29, 2025	$2.23	$1.66	-25.56%
Mar 11, 2025	$7.00	$3.41	-51.29%
Oct 24, 2024	$8.59	$9.12	+6.17%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Zynex (ZYXI) report earnings?

Zynex (ZYXI) is schdueled to report earning on Oct 23, 2025, Before Open (Confirmed).

What is Zynex (ZYXI) earnings time?

Zynex (ZYXI) earnings time is at Oct 23, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ZYXI EPS forecast?

ZYXI EPS forecast for the fiscal quarter 2025 (Q3) is -0.17.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing